Safety and Immunogenicity of a Zoster Vaccine in SLE

NCT02477150 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

90

Enrollment

OTHER_GOV

Sponsor class

Conditions

Systemic Lupus Erythematosus

Interventions

BIOLOGICAL: Zostavax
BIOLOGICAL: placebo

Sponsor

Tuen Mun Hospital